Literature DB >> 30341471

Laparoscopic Hepatectomy Versus Open Hepatectomy for the Management of Hepatocellular Carcinoma: A Comparative Study Using a Propensity Score Matching.

Xavier Untereiner1, Audrey Cagniet2, Riccardo Memeo1,3,4, Zineb Cherkaoui1, Tullio Piardi2, François Severac5, Didier Mutter1,3,4, Reza Kianmanesh2, Taiga Wakabayashi1,3, Daniele Sommacale2, Patrick Pessaux6,7,8,9.   

Abstract

OBJECTIVES: The aim of this study was to compare the results between laparoscopic hepatectomy and open hepatectomy in two French university hospitals, for the management of hepatocellular carcinoma (HCC) using a propensity score matching.
MATERIALS AND METHODS: A patient in the laparoscopic surgery group (LA) was randomly matched with another patient in the open approach group (OA) using a 1:1 allocated ratio with the nearest estimated propensity score. Matching criteria included age, presence of comorbidities, American Society of Anesthesiologists score, and resection type (major or minor). Patients of the LA group without matches were excluded. Intraoperative and postoperative data were compared in both groups. Survival was compared in both groups using the following matching criteria: number and size of lesions, alpha-fetoprotein rate, and cell differentiation.
RESULTS: From January 2012 to January 2017, a total of 447 hepatectomies were consecutively performed, 99 hepatectomies of which were performed for the management of hepatocellular carcinomas. Forty-nine resections were performed among the open approach (OA) group (49%), and 50 resections were performed among the laparoscopic surgery (LA) group (51%). Mortality rate was 2% in the LA group and 4.1% in the OA group. After propensity score matching, there was a statistical difference favorable to the LA group regarding medical complications (54.55% versus 27.27%, p = 0.04), and operating times were shorter (p = 0.03). Resection rate R0 was similar between both groups: 90.91% (n = 30) in the LA group and 84.85% (n =) in the OA group. There was no difference regarding overall survival (p = 0.98) and recurrence-free survival (p = 0.42).
CONCLUSIONS: Laparoscopic liver resection for the management of HCC seems to provide the same short-term and long-term results as compared to the open approach. Laparoscopic liver resections could be considered as an alternative and become the gold standard in well-selected patients.

Entities:  

Mesh:

Year:  2019        PMID: 30341471     DOI: 10.1007/s00268-018-4827-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  60 in total

Review 1.  Laparoscopic liver resections.

Authors:  Chandrakanth Are; Yuman Fong; David A Geller
Journal:  Adv Surg       Date:  2005

2.  Management of hepatocellular carcinoma.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

3.  Laparoscopic liver resection: experience of 53 procedures at a single center.

Authors:  Tom Mala; Bjørn Edwin; Arne R Rosseland; Ivar Gladhaug; Erik Fosse; Oystein Mathisen
Journal:  J Hepatobiliary Pancreat Surg       Date:  2005

4.  Totally laparoscopic right hepatectomy.

Authors:  Brice Gayet; Davide Cavaliere; Eric Vibert; Thierry Perniceni; Hugues Levard; Christine Denet; Christos Christidis; Antoine Blain; Frédéric Mal
Journal:  Am J Surg       Date:  2007-11       Impact factor: 2.565

5.  Laparoscopic versus open liver resection of hepatic neoplasms: comparative analysis of short-term results.

Authors:  B Topal; S Fieuws; R Aerts; H Vandeweyer; F Penninckx
Journal:  Surg Endosc       Date:  2008-07-12       Impact factor: 4.584

6.  Continuous versus intermittent portal triad clamping for liver resection: a controlled study.

Authors:  J Belghiti; R Noun; R Malafosse; P Jagot; A Sauvanet; F Pierangeli; J Marty; O Farges
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

7.  A comparative study of the short-term outcome following open and laparoscopic liver resection of colorectal metastases.

Authors:  T Mala; B Edwin; I Gladhaug; E Fosse; O Søreide; A Bergan; O Mathisen
Journal:  Surg Endosc       Date:  2002-04-09       Impact factor: 4.584

8.  Laparoscopic liver resection: results for 70 patients.

Authors:  I Dagher; J M Proske; A Carloni; H Richa; H Tranchart; D Franco
Journal:  Surg Endosc       Date:  2007-02-08       Impact factor: 4.584

Review 9.  Laparoscopic liver resection for cancer.

Authors:  Kevin Tri Nguyen; T Clark Gamblin; David A Geller
Journal:  Future Oncol       Date:  2008-10       Impact factor: 3.404

10.  Laparoscopic liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: midterm results and perspectives.

Authors:  Daniel Cherqui; Alexis Laurent; Claude Tayar; Stephen Chang; Jeanne Tran Van Nhieu; Jérôme Loriau; Mehdi Karoui; Christophe Duvoux; Daniel Dhumeaux; Pierre-Louis Fagniez
Journal:  Ann Surg       Date:  2006-04       Impact factor: 12.969

View more
  4 in total

1.  Anatomical Versus Non-anatomical Resection for Hepatocellular Carcinoma, a Propensity-matched Analysis Between Taiwanese and Japanese Patients.

Authors:  Shih-Wei Huang; Pei-Yi Chu; Shunichi Ariizumi; Charles Chung-Wei Lin; Hon Phin Wong; Dev-Aur Chou; Ming-Tsung Lee; Hsing-Ju Wu; Masakazu Yamamoto
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

2.  Laparoscopic Caudate Lobectomy for Cholangiocarcinoma of Caudate Lobe Invading Middle Hepatic Vein.

Authors:  Hai-Feng Wan; Kun-Lin Xie; Jia-Xin Li; Kit-Man Ho; Hong Wu; Ji-Wei Huang
Journal:  Ann Surg Oncol       Date:  2020-05-16       Impact factor: 5.344

3.  Survival analysis between laparoscopic and open hepatectomy for hepatocellular carcinoma: a meta-analysis based on reconstructed time-to-event data.

Authors:  Qiang Sun; Xiangda Zhang; Xueyi Gong; Zhipeng Hu; Qiao Zhang; Weiming He; Xiaojian Chang; Zemin Hu; Yajin Chen
Journal:  Hepatol Int       Date:  2021-07-13       Impact factor: 6.047

4.  Laparoscopic versus open left hemihepatectomy for hepatocellular carcinoma: a propensity score matching analysis.

Authors:  Yong Yi; Jialei Weng; Chenhao Zhou; Gao Liu; Ning Ren
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.